Prostate Cancer Treatment Progress Vizag

3596
3.2 Minute

02-09-2024 Team Medicover Oncology

Recent Progress in Prostate Cancer Treatment in Vizag

One of the most prevalent cancers in men globally remains prostate cancer. Although there is undoubtedly considerable progress to be made in our treatment of this ubiquitous disease as we learn more through ongoing medical research. Medicover Hospitals, the leading healthcare provider in India, has taken a giant leap in serving prostate cancer patients by offering advanced treatment options.

This article explores the latest advances in prostate cancer research and treatment provided at Medicover Hospitals including new information on genetics, epidemiology as well as clinical therapies.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Understanding Prostate Cancer

Prostate cancer is a form of the disease that begins in the prostate gland, which helps create semen. Some types of prostate cancer grow so slowly that they may never need treatment, while other types are aggressive and can spread quickly.

Prostate Cancer Genetics

Studies in recent years have demonstrated that genetic factors are important to the initiation and progression of prostate cancer. Doctors and researchers at Medicover Hospitals, Vizag, are working to identify changes in genes (genetic mutations) that might increase the risk of developing prostate cancer.

Key Genetic Findings

BRCA1 BRCA2 Mutations: Initially identified with breast and ovarian cancers, mutations in these genes have more recently been connected with a higher risk of prostate cancer as well. The mutations are also highly enriched in men and substantially increase their risk of developing a potent form of the disease.
A mutation in the HOXB13 gene: A germline variant of the HOXB13 gene has been associated with a specific inherited risk of prostate cancer. This finding opened the door to genetic screening and individualized care for patients with a family history of this disease.

Prostate Cancer Epidemiology

These studies help in understanding the occurrence, distribution, and control of diseases. Medicover Hospitals has carried out an in-depth analysis regarding the epidemiology of prostate cancer in Vizag and the nearby local settings, etc.

Key Epidemiological Insights

Incidence Rates: Data available for years show a consistent rise in the incidence of prostate cancer from Vizag. Growth is mainly driven by a rise in diagnostic techniques as well as increased awareness among the mass population.
Age: Prostate cancer is more common in men over the age of 50 and increases with older age. Knowledge of age-stratified incidence provides insight for focused screening programs aimed at early detection.

Innovative Treatment Options

We at Medicover Hospitals in Vizag offer the most innovative treatment for prostate cancer. Advanced technology combined with personalized care leads to the most favourable outcomes for patients.

Radiation Therapy

In recent years, Prostate Cancer Radiation Therapy has become more accurate and efficient, causing less harm to the healthy tissue around it.

Intensity-Modulated Radiation Therapy (IMRT): IMRT delivers high doses of radiation to the prostate but does so in a way that avoids nearby organs. This approach minimises the side effects and offsets their quality of life to some levels.
Stereotactic Body Radiation Therapy (SBRT): This concentrates the radiation dose to a tumour target and delivers larger doses of radiation in fewer treatment sessions. This is of greatest value among men with low-risk prostate cancer.

Hormone Therapy

Androgen Deprivation Therapy (ADT) or Hormone therapy is intended to decrease male hormones that incite the expansion of prostate cancer cells.

LHRH Agonists and Antagonists is a slow cancer growth through lower testosterone levels. Many are used in conjunction with other treatments for the best outcomes.
Anti-Androgens stop testosterone from interacting with the cancer cells and so prevent them from growing. This method works well in cases of advanced prostate cancer.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Prostate Cancer Research at Medicover Hospitals

Research is key to success in prostate cancer treatment at Medicover Hospitals. The school is dedicated to enhancing medical knowledge and patient outcomes through scientific research.

Clinical Trials and Studies

Medicover Hospitals benefits from clinical trials and studies, which help it determine which new treatments and therapies should be upgraded. The patients involved in these trials have early access to therapies that may be years away from being widespread.

Immunotherapy Trials: Immunotherapy uses the body’s immune system to fight cancer. Trials currently underway at the various Medicover Hospitals are also examining investigational drugs, including immunotherapy-based treatments for the management of prostate cancer.
Targeted Therapy Trials: Targeted therapy is designed to attack specific molecules involved in the growth of cancer cells. Researchers are investigating how targeted drugs may be used to treat prostate cancer in its early stages and for advanced disease.

Collaborative Research Efforts

Medicover Hospitals also partners with other top research institutions and universities worldwide to widen the common pool of knowledge. This collaborative strategy speeds the process of discovery and transformation for patients with the most recent discoveries in prostate cancer research.

The Role of a Cancer Specialist

The cancer specialist, or oncologist, helps in the diagnosis and treatment of prostate cancer. Medicover Hospitals is supported by a multidisciplinary team of specialists who combine their expertise and create individualised treatment plans for patients.

Expertise and Experience

At Medicover Hospitals, we have some of the best cancer specialists in the country who are adept at treating prostate cancer. They stay current with the most recent studies and therapeutic interventions to provide top-quality care.

Personalised Treatment Plans

Realizing that each patient is different, the oncologists at Medicover Hospitals chart personalized treatment protocols for everyone, considering their history and current health conditions. This is one way to ensure maximum potential results with minimal side effects.

Prostate Cancer Causes and Risk Factors

It is also important to be aware of what causes or risk factors could lead to the development of prostate cancer in order to prevent, diagnose and detect this type of sickness early. We do not know exactly what causes prostate cancer, although certain risk factors have been associated with the disease.

Key Risk Factors

Age because the risk of prostate cancer increases with age, it's quite uncommon in men under 50.
Family History: Having an affected family member increases risk by over four to fivefold, really highlighting the importance of genetic screening.
Race and Ethnicity: Prostate cancer occurs more often in African American men and less frequently in Asian American or Hispanic men.
Diet and lifestyle: Eating a lot of red meat and dairy products might increase the risk of being overweight, as may be the case.

Conclusion

The recent success of prostate cancer research and treatment at Medicover Hospitals in Vizag is a testament to their professionalism and dedication. Integrating genetic studies, core epidemiological studies, and recent effective treatment options have made Medicover Hospitals a pioneer in prostate cancer care.

Frequently Asked Questions

Recent progress may include new treatment options, advancements in surgical techniques, and findings from hospitals. Local research institutions contribute to these developments.

Stay informed through local cancer research institutions, medical journals, and healthcare providers. Attend seminars and read updates on recent findings.

Medicover Hospitals is available. Contact us for information on current trials and eligibility criteria.

New findings can lead to more effective treatments, improved patient outcomes, and personalized care. They provide options for better management of prostate cancer.

Institutions such as Medicover Hospitals, research hospitals, and universities may be involved. Contact them for information on ongoing research and participation opportunities.

Participate by enrolling in hospital or research studies. Consult with your oncologist to learn about opportunities and potential benefits.